The Fidelity High Dividend ETF (FDVV) offers a much-above-average yield but has several megacap tech names as its top holdings.
That gives the portfolio a unique "growth plus income" profile that's rare in the dividend ETF space.
Healthy corporate earnings growth expectations could help fuel outperformance.
If I had $1,000 to invest in a single dividend ETF right now, I wouldn't choose one solely for its high yield. I'd be looking more for total return -- a combination of income today and the potential for long-term growth. And I want enough exposure to growing companies to keep building wealth for years to come.
That's why the Fidelity High Dividend ETF (NYSEMKT: FDVV) would be my current choice.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Since its inception a decade ago, this fund has produced an average annual return of 13.5%. While its current dividend yield of 2.6% isn't necessarily the highest you can find in this category, it's still roughly 2.5 times that of the S&P 500 (SNPINDEX: ^GSPC). Plus, its overall combination of growth and income positions it as an above-average long-term holding.
Image source: Getty Images.
The Fidelity High Dividend ETF's underlying index doesn't simply look for high-yielding stocks.
Dividend yield accounts for 70% of the selection process criteria's weighting, while the payout ratio and dividend growth rate each account for 15%. That means dividend quality and dividend growth are considered when building the portfolio.
From there, the selection process gets a little complicated. Much of a stock's weight in the portfolio is anchored to its market cap. That's why Nvidia is the fund's top holding, with a 7.3% weighting, despite paying only around 0.5% yield.
While the portfolio construction process ultimately creates a portfolio that's a bit counterintuitive, there are a couple of things I like about it:
The economic picture is still mixed, but it's unquestionably supported by strong corporate earnings growth. Jobs are being added at an inconsistent rate. Inflation and oil prices are high. The Fed just hiked interest rates by a quarter-point and signaled another rate hike could come before the end of the year.
But corporate earnings in the U.S. are expected to keep growing at a healthy clip. Much of this is driven by the artificial intelligence (AI) development boom, but we're seeing profits grow across companies of all sizes. As long as earnings are growing at double-digit rates, the path to higher stock prices should be well supported.
Because the Fidelity High Dividend ETF's portfolio is more heavily tilted toward growth companies, it could experience above-average gains. And that's why I think it's a strong buy candidate right now.
Before you buy stock in Fidelity Covington Trust - Fidelity High Dividend ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Fidelity Covington Trust - Fidelity High Dividend ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $412,074!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,314,319!*
Now, it’s worth noting Stock Advisor’s total average return is 932% — a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of September 18, 2026.
David Dierking has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy.